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The correct functioning of the nervous system depends on the exquisitely fine control
of neuronal excitability and synaptic plasticity, which relies on an intricate network of
protein-protein interactions and signaling that shapes neuronal homeostasis during
development and in adulthood. In this complex scenario, Kinase D interacting substrate
of 220 kDa/ankyrin repeat-rich membrane spanning (Kidins220/ARMS) acts as a
multi-functional scaffold protein with preferential expression in the nervous system.
Engaged in a plethora of interactions with membrane receptors, cytosolic signaling
components and cytoskeletal proteins, Kidins220/ARMS is implicated in numerous
cellular functions including neuronal survival, neurite outgrowth and maturation and
neuronal activity, often in the context of neurotrophin (NT) signaling pathways. Recent
studies have highlighted a number of cell- and context-specific roles for this protein in
the control of synaptic transmission and neuronal excitability, which are at present far
from being completely understood. In addition, some evidence has began to emerge,
linking alterations of Kidins220 expression to the onset of various neurodegenerative
diseases and neuropsychiatric disorders. In this review, we present a concise summary
of our fragmentary knowledge of Kidins220/ARMS biological functions, focusing on
the mechanism(s) by which it controls various aspects of neuronal activity. We have
tried, where possible, to discuss the available evidence in the wider context of
NT-mediated regulation, and to outline emerging roles of Kidins220/ARMS in human
pathologies.
Keywords: Kidins220/ARMS, BDNF, sodium channels, glutamate receptors, synaptic plasticity, neuronal
excitability, neurodegeneration
Abbreviations: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF, brain-derived neurotrophic factor;
EPSC, excitatory post-synaptic current; GABA, gamma-aminobutyric acid; GluA1, glutamate receptor A1; IPSC, inhibitory
post-synaptic current; Kidins220/ARMS, Kinase D interacting substrate of 220 kDa/ankyrin-repeat-rich membrane spanning;
LTP, long-term potentiation; Nav, voltage-gated Na+ channel; NGF, nerve growth factor; NMDA, N-methyl-D-aspartate;
NMDAR, NMDA receptor; NT, neurotrophin; Trk, tropomyosin-related kinase.
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INTRODUCTION
To maintain the proper function of the nervous system,
neuronal excitability and synaptic plasticity are continuously
modulated in response to endogenous activity and external
stimuli. A constantly increasing number of signaling and
adaptor proteins form a network that contributes to maintain
the balance between homeostatic compensation and experience-
induced modifications during development and in adulthood.
The picture however is still far from being complete, and
new players are continuously added to this already complex
scenario. Amongst such ‘‘new entries’’, the Kinase D interacting
substrate of 220 kDa/ankyrin-repeat-rich membrane spanning
(Kidins220/ARMS, henceforth referred to as Kidins220) is
a membrane protein preferentially expressed in the nervous
system, where it modulates several crucial aspects of neuronal
physiology such as cell survival, differentiation into axons
and dendrites, and synaptic plasticity (Neubrand et al., 2012).
Kidins220 is a large four-pass membrane protein that acts
as a scaffolding protein and signaling platform at the plasma
membrane. Its long amino (N)- and carboxy (C)-terminal
tails are exposed to the cytoplasm and contain a number of
protein-protein interaction modules that mediate most of the
known Kidins220 functions. The N-terminal region is largely
occupied by 11 contiguous ankyrin repeats that mediate the
interaction with the Rho-guanine exchange factor (Rho-GEF)
Trio and the rearrangements of the actin cytoskeleton triggered
by nerve growth factor (NGF) signaling (Neubrand et al.,
2010). The C-terminal tail contains several residues subjected
to post-translational modifications, including phosphorylation,
ubiquitination and calpain cleavage, and regions modulating
the binding to a number of molecular interactors amongst
which adaptor proteins of the mitogen-activated protein kinase
(MAPK) pathway (Proline-rich domain; Arévalo et al., 2006), the
molecular motor kinesin-1 [kinesin-interacting motif (KIM)]
(Bracale et al., 2007), and the neurotrophin (NT) receptor
p75NTR [PSD-95/Disc large/Zonula occludens-1 (PDZ)-
binding motif] (Kong et al., 2001). Other interactions, e.g.,
with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptor subunits and tropomyosin-related kinase
(Trk)-type NT receptors, appear to be mediated by its trans-
membrane domains (Arévalo et al., 2004, 2010). Kidins220
does not possess a catalytic function itself, but the interaction
with target proteins is modulated by phosphorylation at
multiple sites. Kidins220 is ubiquitously expressed in the
central nervous system (CNS) and peripheral nervous system
(PNS), being present in excitatory and inhibitory neurons, as
well as in glial cells. At the subcellular level, Kidins220 shows
no preferential localization or targeting, as it is present all
over the cell body, dendrites and axons. Over the years, the
majority of studies have focused on the role played by Kidins220
in the modulation of the intracellular signaling cascades
initiated by NTs, in particular by brain-derived neurotrophic
factor (BDNF) binding to its cognate receptor, TrkB. An
increasing amount of data indicates that this protein plays
different roles in the control of neuronal activity, which
are cell- and context-specific, and that dysregulation of
its function can lead to pathological consequences. In this
review, we summarize the available data on the subject. This
effort will hopefully help putting into context the various
functions of Kidins220 in the modulation of neuronal
communication and excitability, also and particularly with
regard to NT-mediated regulation, which is at present far better
understood.
KIDINS220 AND THE REGULATION OF
NEURONAL ACTIVITY
In addition to their classical functions in neuronal survival
and differentiation, NTs—and in particular BDNF—have also
been recognized as potent modulators of neuronal activity,
working at multiple levels ranging from synapse formation and
morphology to the dynamic modification of synaptic efficacy
and membrane excitability (Poo, 2001; Blum and Konnerth,
2005; Gottmann et al., 2009; Edelmann et al., 2014). As a
distinct down-stream target of activated NT receptors, it may
not surprise that Kidins220 has been implicated in the molecular
mechanisms controlling neuronal activity. In only few cases,
however, the role of Kidins220 has been directly related to
BDNF signaling events, while it mostly appears to function
independently of BDNF, or at least, this relation has not been
investigated.
These studies have relied on acute modifications of Kidins220
expression level by overexpression or gene silencing and the
use of two independent Kidins220 knockout mouse lines.
Homozygous knockout mice described by Wu et al. (2009) die
very early during embryonal development, precluding further
studies. Despite grossly normal brain development, heterozygous
ARMS+/− mice having 60–70% of normal Kidins220 protein
levels were used as a model for reduced Kidins220 expression
(Wu et al., 2009). Studies on the effects of constitutive Kidins220
ablation have been possible with the generation of a second
Kidins220 knockout mouse line by Cesca et al. (2011, 2012),
in which embryos survived until late stages of gestation. These
embryos showed, among other phenotypes, a high degree of
neuronal cell death in the CNS and impairments in the neuronal
responses towards neurotrophic stimuli (Cesca et al., 2011,
2012).
Roles of Kidins220 in Synaptic
Transmission and Plasticity
Among the studies conducted so far on this topic, there are
only two examples directly investigating the relationship to
TrkB/BDNF signaling. Both reports investigated well-known
BDNF effects acting on the efficacy of synaptic vesicle release.
Firstly, Sutachan et al. (2010) transiently altered Kidins220 levels
in rat hippocampal pyramidal neurons (by over-expression and
knock-down approaches) and found corresponding changes in
the strength of gamma-aminobutyric acid (GABA)ergic inputs
arriving at these neurons (Sutachan et al., 2010). Notably, the
enhancement of GABAergic transmission in neurons chronically
exposed to BDNF, which is known to boost GABA synthesis
and release in inhibitory synapses (Bolton et al., 2000; Baldelli
et al., 2002; Ohba et al., 2005), was completely abolished by
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FIGURE 1 | (A) Pre-synaptic roles of Kidins220. In GABAergic neurons (left), Kidins220 exerts negative effects on Nav channel activity and on the recovery of
neurotransmitter release upon stimulation. In glutamatergic neurons (right), Kidins220 favors the brain-derived neurotrophic factor (BDNF)-dependent stimulation of
glutamate release. (B) Post-synaptic roles of Kidins220 (in glutamatergic neurons). (a) At synaptic contacts between pre-synaptic inhibitory neurons and
post-synaptic excitatory neurons, the presence of Kidins220 in the post-synaptic compartment favors the BDNF-dependent potentiation of pre-synaptic strength,
possibly by modulating TrkB-dependent retrograde signaling events. (b) At synaptic contacts between pre-synaptic excitatory neurons and post-synaptic excitatory
neurons, the presence of Kidins220 at dendritic spines negatively regulates the incorporation of the amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor subunit GluA1 into the plasma membrane, apparently in the opposite manner compared to BDNF, which is known to potentiate excitatory synapses by
increasing the number of GluA1 at the membrane. Altogether, these effects are expected to impact on the excitation/inhibition balance, and consequently on
network excitability. For both panels, please refer to the main text for a detailed discussion of possible mechanisms involved and for references to the published
literature. Kidins220 action is represented as a red minus “−” when Kidins220 inhibits the process, and as a red plus “+” when Kidins220 favors the process. On the
basis of the published literature, the role played by BDNF in the same phenomena is also represented as a blue plus symbol.
Kidins220 knock-down. In the second case, the stimulation of
excitatory post-synaptic currents (EPSCs) elicited by acutely
applied BDNF (Levine et al., 1995; Lessmann and Heumann,
1998) was impaired in cultured Kidins220−/− hippocampal
neurons, in line with the decreased neuronal sensitivity towards
neurotrophic stimuli in this mouse strain (Cesca et al., 2012).
While both pre- and post-synaptic effects of BDNF have been
described in different preparations (Gottmann et al., 2009), this
kind of enhancement appears predominantly of pre-synaptic
origin, since basal glutamate release is stimulated by concomitant
increases of the size of the readily releasable vesicle pool and
the probability of vesicle release (Valente et al., 2012). Together,
these results support the idea that Kidins220 is critically
involved in the pre-synaptic BDNF signaling pathway acting on
glutamate release (Figure 1A) as well as in post-synaptic TrkB-
dependent retrograde signaling events acting on GABA release
(Figure 1Ba).
In other studies, a direct relation to TrkB/BDNF signaling
events is missing, yet a survey of the literature suggests hidden
links that may deserve further investigation, in particular
regarding the association of Kidins220 with subunits of two
main classes of post-synaptic glutamate receptors. Starting
from the observation that basal synaptic transmission was
slightly increased in hippocampal slices prepared from 1-
month-old ARMS+/− mice, Arévalo et al. (2010) proposed that
Kidins220 associates with the AMPA-type glutamate receptor
subunit A1 (GluA1) and regulates its phosphorylation state and
localization. Accordingly, Kidins220 overexpression or knock-
down in rat organotypic brain slices caused inverse changes
in GluA1 surface expression and in the amplitude of AMPA
receptor-mediated EPSCs (Arévalo et al., 2010). Moreover, it
is tempting to relate the Kidins220-GluA1 association also to
long-term potentiation (LTP) of excitatory responses, since LTP
at hippocampal Schaffer collateral—Cornu Ammonis 1 (CA1)
synapses was increased in 3–6-month-old ARMS+/− mice (Wu
et al., 2010). LTP at this synapse has been predominantly
attributed to changes in the number and biophysical properties of
AMPA receptors (Lee and Kirkwood, 2011). Notably, ARMS+/−
hippocampal slices and Kidins220-depleted neurons showed
increased GluA1 phosphorylation at two serine residues, S831
and S845 (Arévalo et al., 2010), both of which are known to
contribute to LTP induction at Schaffer collateral-CA1 synapses
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FIGURE 2 | A potential “TrkB/BDNF—Kidins220—ion channel” network. This cartoon summarizes the known physical (black lines) and functional (blue arrows)
interactions at present demonstrated for Kidins220, the NT receptor TrkB and its ion channel targets, i.e., subunits of AMPA-type and NMDA-type glutamate
receptors as well as Nav channels. (A) In the case of the Kidins220-AMPAR interaction, it is known that Kidins220 modulates the surface expression and
phosphorylation state of the GluA1 subunit. Phosphorylation of the same subunit is known to be modulated by TrkB activation via CaM kinase. (B) Kidins220
interacts with the NR1, NR2A and NR2B subunits of NMDAR. TrkB activation modulates NMDAR phosphorylation via Fyn kinase. (C) Kidins220 interacts with
Nav1.2 modulating channel kinetics and voltage-dependence. TrkB activation modulates Nav1.2 channel function via phosphorylation mediated by Fyn kinase, while
dephosphorylation is mediated by receptor-type protein tyrosine phosphatase β (RPTPβ). For details refer to the main text.
(Lee et al., 2003, 2010). These observations are circumstantial, as
a direct link connecting the Kidins220-GluA1 association to LTP
is still missing. Furthermore, increased LTP in ARMS+/− mice
was not due to reduced Kidins220 levels per se, but required
further activity-dependent proteolytic degradation mediated by
calpain protease (Wu et al., 2010), suggesting that the absolute
value of the Kidins220 steady-state level may be important for
the dynamic modulation of synaptic plasticity at glutamatergic
synapses. Further work is needed to clarify the position of
Kidins220 in these molecular pathways, also considering that
Kidins220 associates both with TrkB and GluA1 receptors
(Figure 2). BDNF is a potent regulator of hippocampal LTP
with numerous roles (Leal et al., 2014). Recently, it has been
demonstrated that BDNF regulates synaptic AMPA receptor
incorporation in a form of spike-timing-dependent LTP at
Schaffer collateral inputs (Edelmann et al., 2015). It has also
been reported that short-term treatment with BDNF causes
an increase in GluA1 surface expression in rat hippocampal
neurons, mediated by the activation of the Ca2+/calmodulin-
dependent (CaM) kinase pathway (Fortin et al., 2012) and
phosphorylation of GluA1 at S831 (Caldeira et al., 2007;
Figure 2). With our current knowledge, we can only take note
of the unexpected fact that the effect of reduced Kidins220 levels
appears to mirror the BDNF effect on GluA1 phosphorylation
and surface expression (Figure 1Bb). It also remains to be
determined which may be the consequences of the Kidins220-
GluA1 association for the biophysical properties of the respective
AMPA-type glutamate receptors.
Furthermore, Kidins220 was also shown to associate with
the NR1, NR2A and NR2B subunits of neuronal N-methyl-
D-aspartate (NMDA) receptors (López-Menéndez et al.,
2009), a class of glutamate receptors particularly critical for
LTP induction, due to their specific functional properties
combining glutamate- and voltage-gated activation with calcium
permeability. Unfortunately, possible roles of the Kidins220
association in NMDAR trafficking or function are at present
completely unexplored. The situation is different for the
TrkB/BDNF system, which may therefore guide future efforts
related to the role of Kidins220 in this context. BDNF is known
to stimulate the rapid phosphorylation of the NR1 and NR2B
(but not NR2A) subunits (Suen et al., 1997; Lin et al., 1998)
and increase the open probability of NMDARs, ultimately
leading to an enhancement of excitatory synaptic transmission
(Levine et al., 1998). Similar tyrosine phosphorylation of
NR2B has also been observed after LTP induction in the rat
dentate gyrus (Rostas et al., 1996). A subsequent study showed
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the importance of BDNF-stimulated NR2B phosphorylation
for spatial memory formation and suggested the Src-family
tyrosine kinase Fyn, which interacted with both TrkB and
NR2B, as a possible link (Figure 2; Mizuno et al., 2003).
However, a direct connection between BDNF-stimulated
NMDAR phosphorylation and hippocampal LTP remains to be
demonstrated.
In summary, the studies related to modified (but not
constitutively abolished) Kidins220 expression reveal a picture
in which basal synaptic transmission in both GABAergic and
glutamatergic synapses are affected in opposite ways: while post-
synaptic responses in the former were reduced by Kidins220
knockdown (Sutachan et al., 2010), responses in the latter were
increased (Arévalo et al., 2010; Wu et al., 2010). Contrarily
to what may be expected from these results, hippocampal
neurons derived from full Kidins220 knockout embryos did
not show an impairment in basal synaptic transmission (Cesca
et al., 2012; Scholz-Starke et al., 2012). It is conceivable that
the lack of Kidins220 in these neurons may be compensated
by homeostatic mechanisms to various extents, depending on
its specific function in the process under study. Importantly,
recordings on Kidins220−/− neurons revealed an entirely novel
function of the Kidins220 protein in the control of synaptic
plasticity, which apparently cannot be covered by compensatory
mechanisms. It should be noted that this function (similarly to a
further one related to neuronal excitability, which is discussed
below) was associated with GABAergic hippocampal neurons,
but apparently absent in glutamatergic neurons. Inhibitory post-
synaptic currents (IPSCs) of Kidins220−/− neurons recovered
considerably faster from synaptic depression than those recorded
from wild-type neurons (Scholz-Starke et al., 2012). In response
to two different stimulation paradigms, paired-pulse and long-
lasting train stimulation, the kinetics of recovery of wild-type
IPSCs was biphasic, displaying fast and slow components similar
to what has been reported for IPSCs in collicular neurons
and hippocampal basket cell—granule cell synapses (Kraushaar
and Jonas, 2000; Kirischuk et al., 2002). Contrarily, the slow
component of recovery for Kidins220−/− IPSCs was consistently
reduced in both paradigms, while the fast component was
unaffected. In wild-type neurons, the slow component was
independent of synaptic vesicle depletion, but apparently linked
to a transient reduction of vesicle release probability (Scholz-
Starke et al., 2012). Therefore, these data suggest an essential
role for Kidins220 in the transient, activity-dependent reduction
of GABA release in hippocampal synapses (Figure 1A), but the
exact mechanisms remain to be determined. Also in view of
this novel function in synaptic plasticity, it may be interesting
to transiently modify Kidins220 expression specifically in
GABAergic neurons.
Kidins220 as a Target of Neuronal Activity
In addition to its role as a player participating in the control
of neuronal activity, it turned out that Kidins220 itself is a
target of proteolytic degradation mediated by Ca2+-dependent
calpain proteases, the activation of which is triggered by neuronal
activity. Calpains do not degrade their targets completely, unlike
typical cellular proteases, but function to regulate their activity
by partial cleavage, thereby contributing to synaptic plasticity
and neurotoxicity (Baudry et al., 2013). As a calpain target,
Kidins220 is in the company of TrkB and numerous synaptic
proteins, among which SNAP (Soluble NSF Attachment Protein)
receptor (SNARE) proteins, glutamate receptor subunits, protein
kinases, cytoskeletal and other scaffold proteins, just to name a
few (Baudry et al., 2013). Kidins220 degradation was observed
in response to excitotoxic overstimulation of cortical NMDARs,
leading to neuronal death (López-Menéndez et al., 2009), but
also following physiological activity in hippocampal neurons
triggered by glutamate or KCl-elicited depolarization (Wu et al.,
2010). Chronic activity stimulation by the GABAA receptor
antagonist bicuculline also caused a small decrease of Kidins220
protein levels in hippocampal neurons (Cortés et al., 2007).
Although the mechanisms leading to Kidins220 downregulation
are different in these studies, they all point to activity-dependent
proteolytic Kidins220 degradation. This could be relevant in
cases of pathological hyperexcitation, such as epileptic seizures,
which cause, amongst many effects, also an increase in BDNF.
Interestingly, calpain activity has been recently shown to affect
the availability of other proteins controlling neuronal excitability,
such as the K+/Cl− co-transporter KCC2, during neonatal
seizures (Puskarjov et al., 2015). Conversely, Kidins220 amounts
tended to increase in neurons subjected to chronic activity
blockade by tetrodotoxin, a potent inhibitor of voltage-gatedNa+
(Nav) channels (Cortés et al., 2007). In this case, the underlying
mechanism is at present unknown, yet Kidins220 accumulation
may be simply due to reduced proteolytic degradation under
conditions of activity blockade. Alternatively, it might be related
to homeostatic synaptic scaling operating to restore normal
synaptic activity under these conditions (Turrigiano, 2008). Once
again, BDNF is among the factors regulating synaptic scaling.
In fact, TrkB receptor inhibition mimics the effects of chronic
activity blockade, and further, scaling up of synaptic strength is
prevented by application of exogenous BDNF (Rutherford et al.,
1998). In any case, it appears certain that Kidins220 is a target
of activity-dependent regulation, while there is no indication
for a possible role as activity sensor, as initially proposed by
Cortés et al. (2007) on the basis of the reciprocal relationship
between neuronal activity and Kidins220 levels and further data
showing that Kidins220 knock-down enhanced synaptic activity.
While the mechanisms responsible for the enhancement were
not further specified in this study, it seems now clear, in the
light of subsequent studies discussed above, that they combined
an increase of glutamatergic synaptic transmission (Wu et al.,
2010) with a decrease of GABAA receptor-mediated inhibition
(Sutachan et al., 2010).
A Novel Role of Kidins220 in the Control
of Neuronal Excitability
Constitutive Kidins220 ablation also affected the intrinsic
excitability of GABAergic hippocampal neurons. Specific
alterations in action potential shape strongly suggested an
increased sodium conductance in Kidins220−/− inhibitory
neurons, possibly caused by aberrant activity of Nav channels
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(Cesca et al., 2015). Biochemical studies confirmed that
Kidins220 associates with alpha subunits of native Nav channels
in the brain and specifically with sodium channels formed by
the major brain Nav channel alpha subunit Nav1.2 in human
embryonic kidney (HEK)293 cells. Recordings of sodium
currents mediated by heterologously expressed Nav1.2 further
revealed dramatically slowed channel kinetics and shifted
voltage-dependence in Kidins220-coexpressing cells, indicating
that Kidins220 association can have unexpectedly strong effects
on both Nav channel activation and fast inactivation processes
(Cesca et al., 2015). These data suggest that Kidins220 exerts
a negative influence on Nav channel activity in GABAergic
neurons (Figure 1A).
This kind of modulation differed in several aspects from the
regulation of Nav1.2 channels by Fyn tyrosine kinase in response
to the activation of the TrkB/ BDNF pathway (Ahn et al., 2007).
First, the effects depended solely on Kidins220 co-expression,
but not on further constituents of the TrkB signaling pathway
or BDNF application. Second, Nav1.2 phosphorylation by Fyn
did not affect channel activation, but only fast inactivation,
and third, it accelerated inactivation and shifted its voltage-
dependence towards negative membrane potentials, i.e., in the
opposite direction compared to Kidins220. The activity of brain
Nav1.2 channels appears to be modulated by Fyn-mediated
phosphorylation, which can be reversed by dephosphorylation
catalyzed by the receptor-type protein tyrosine phosphatase β
(RPTPβ; Figure 2; Ratcliffe et al., 2000). A radically different
mode of BDNF action has been proposed for the alpha subunit
Nav1.9, in which TrkB activation directly elicits the rapid
activation of sodium currents by an as yet unknown mechanism
(Blum et al., 2002). Although these results have not been
reproduced by other groups and are therefore not generally
accepted, it is notable that focal BDNF application elicited fast
calcium transients in the dendrites of hippocampal neurons,
which required the activity of Nav channels, in addition to TrkB
receptors and voltage-dependent Ca2+ channels (Lang et al.,
2007). Future studies related to cell type/subunit specificities
and the molecular mechanism of the Kidins220-Nav channel
interaction may also reveal if and how it relates to the Fyn-
mediated modulation and more generally to the TrkB/BDNF
pathway. A further aspect of the interaction concerns its sub-
cellular localization within the neuron. Nav channel clustering
at the axon initial segment and nodes of Ranvier is crucial for
reliable action potential generation and conduction. Clustering
is achieved by the adaptor protein ankyrin-G, which links
Nav channels to the actin/spectrin cytoskeleton (Zhang and
Bennett, 1998; Garrido et al., 2003). Similarly, the ankyrin repeats
present in the Kidins220 N-terminus may be involved in Nav
channel association and possibly interfere with normal channel
clustering.
At the single-neuron level, Kidins220−/− GABAergic neurons
displayed increased excitability, which manifested itself as
a reduction of threshold currents required to elicit action
potentials and increased firing frequencies compared to wild-
type neurons (Cesca et al., 2015). Misregulation of Nav channels
contributes to some extent to these phenotypic changes, but
given the complexity of neuronal firing, one cannot exclude
that further, as yet unidentified molecular mechanisms will add
to it. Finally, multi-electrode array recordings of Kidins220−/−
hippocampal networks revealed reduced spiking activity in
response to low-frequency pulse stimulation (Cesca et al.,
2015), suggesting that the phenotypic changes observed in
Kidins220−/− GABAergic neurons translate into specific changes
of network excitability. These results were consistent with the
idea that reverberating network excitation was suppressed by
a potentiation of inhibitory neuronal circuits. It remains to be
determined if the occurrence of two gain-of-function phenotypes
specifically in GABAergic Kidins220−/− neurons identifies a
regulatory role of the protein in the weight of synaptic inhibition
and ultimately in the balance between excitation and inhibition
in neuronal networks.
KIDINS220 FUNCTIONS RELATED TO
PATHOLOGIES
Studies performed on Kidins220 mutant mice indicate that the
alteration of Kidins220 protein levels impairs neuronal survival
and development. The complete ablation of Kidins220 led to
embryonic death, which was associated to extensive apoptosis in
the CNS and PNS and to cardiovascular abnormalities (Cesca
et al., 2011, 2012). A partial reduction of Kidins220 levels
was sufficient to cause defects in spine turnover and synaptic
plasticity, with significant repercussions on higher functions
such as learning and memory, when studied in adult mice (Wu
et al., 2009, 2010; Arévalo et al., 2010; Duffy et al., 2011). Taken
together, the results of these studies strongly support the idea
that alterations of the KIDINS220 gene and/or the Kidins220
protein may associate with human (neuro)pathologies. Although
the literature concerning this aspect of Kidins220 function
is still limited, several studies have started to investigate the
genetic and molecular pathways linking Kidins220 to the onset
of various diseases. For example, Kidins220 is overexpressed
in human samples of melanoma (Liao et al., 2007, 2011), a
tumor of neural crest origin, and of neuroblastoma (Rogers
and Schor, 2013a,b; Jung et al., 2014), a cancer type affecting
the PNS. In both cases, Kidins220 behaves as an oncogene,
affecting the ability of cancer cells to survive, proliferate and
migrate/metastasize. Increased Kidins220 levels have also been
observed in human Alzheimer’s Disease (AD) samples (López-
Menéndez et al., 2013). Here, Kidins220 accumulated with
hyperphosphorylated Tau protein, probably contributing to the
defective NT signaling observed in this pathology. Alterations
of KIDINS220 gene expression have been found in several
genetic screens in humans. For example, a microarray-based
expression profiling of dopaminergic neurons isolated from the
substantia nigra of Parkinson’s Disease (PD) patients revealed
that Kidins220 levels were significantly decreased compared to
controls (Simunovic et al., 2009). Another study analyzed the
blood transcriptome from Autism Spectrum Disorder (ASD)
patients, and found increased levels of Kidins220 mRNA in ASD
patients. Interesting, genes belonging to the NT pathways were
overall the most represented amongst the affected genes (Kong
et al., 2012). Finally, a very recent study was conducted on a small
number of schizophrenia patients, by means of high-coverage
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TABLE 1 | Pathologies associated to mutations of the Kidins220 gene or alterations of Kidins220 protein levels.
Disease Mutation Physiological Organism Reference
effects
Melanoma Increased levels Cell survival, anchorage-
independent growth/metastasis
Human, mouse Liao et al. (2007, 2011)
Neuroblastoma Increased levels N-type to S-type transition,
NGF-mediated signaling, cell
proliferation
Human, mouse Rogers and Schor (2013a,b),
Jung et al. (2014)
Pediatric high-grade glioma Intragenic copy number breakpoint n.d. Human Carvalho et al. (2014)
Alzheimer’s disease Increased levels Decreased Kidins220 clearance
and impaired NT signaling
Human López-Menéndez et al. (2013)
Parkinson’s disease Reduced levels n.d. Human Simunovic et al. (2009)
Autism spectrum disorders Copy number variation (increase) n.d. Human Kong et al. (2012)
Autism spectrum disorders Deletion of genomic region n.d. Human Pinto et al. (2014)a
Schizophrenia Two missense polymorphisms (A1299G,
A557V), one novel variant (H1085R)
n.d. Human Kranz et al. (2015) and
Malaspina et al. (2016)
n.d., not determined. aDeletion of the genomic region containing Kidins220 was identified in 3 out of 2446 cases analyzed, however it did not pass subsequent quality
controls and was not further investigated.
targeted exome capture on a small number of NT-related genes
from blood leukocytes. Interestingly, two KIDINS220 missense
polymorphisms and one novel gene variant were identified in 5
out of 48 schizophrenia patients (Kranz et al., 2015). One of these
polymorphisms has been subsequently associated to reduced
prefrontal rostralization in schizophrenia patients, compared to
healthy control subjects (Malaspina et al., 2016). A schematic
summary of the pathologies that have been associated with
Kidins220 to date is reported in Table 1.
OUTLOOK
The scaffold protein Kidins220, originally described as the first
physiological substrate of Protein Kinase D (PKD) and as an
immediate down-stream target of NT receptor kinases, has
emerged as a novel player in the control of neuronal activity.
However, our understanding of this role is currently far from
being complete, and it is also unclear how it relates to the recent
identification of Kidins220 in several neurological diseases. This
summary may serve to focus on gaps in our knowledge on the
subject and possibly to guide future investigations.
At the cellular level, it will be important to clarify which cases
of recognized Kidins220-mediated regulation are de facto part
of TrkB/BDNF signaling events and which are not. There is a
multitude of mechanisms by which BDNF impacts on synaptic
transmission and membrane excitability and which might also
involve Kidins220. In fact, the list of ion channels targeted by the
BDNF signaling pathway has grown considerably in recent years
and now includes, apart from the above-mentioned NMDARs
(Levine et al., 1998) and voltage-gated sodium channels (Ahn
et al., 2007), also TRP-type non-selective cation channels (Li
et al., 1999; Amaral et al., 2007), several types of potassium
channels (Rogalski et al., 2000; Tucker and Fadool, 2002; Nieto-
Gonzalez and Jensen, 2013) and voltage-gated calcium channels
(Baydyuk et al., 2015). The current picture that has emerged
from the available data shows that Kidins220 associates with
subunits of voltage-gated sodium channels and two classes of
neuronal glutamate receptors, which are, for their part, strongly
modulated by the TrkB/BDNF system (Figure 2). This raises the
question whether the target proteins are part of the same local
signaling complex or, alternatively, if there are distinct, spatially
separated Kidins220 pools operating with TrkB and different
types of membrane receptors. In this context, it may also be
relevant to note that Kidins220 has been found associated to lipid
rafts (Cabrera-Poch et al., 2004), for which a connection to NT
signaling in synapses has been proposed (Zonta and Minichiello,
2013). More work is needed to investigate a possible Kidins220
association with other ion channels known to be modulated
by BDNF. It is also unknown whether a connection exists
between Kidins220 and Fyn kinase, which has been identified as
a mediator in the BDNF modulation of Nav1.2 and NMDARs
(Mizuno et al., 2003; Ahn et al., 2007).
Among the plethora of known Kidins220 interactions, for
some it is known that Kidins220 can induce post-translational
modifications of partner proteins, even though this aspect has
been investigated only in a minority of studies (Table 2). Since
Kidins220 does not seem to possess any kind of enzymatic
activity, such effects must necessarily be indirect, most probably
through the assembly of multi-protein complexes where the
modifying enzyme and its target protein are brought in close
proximity by means of the Kidins220 scaffold. This is indeed a
topic worth pursuing, since it may give a strong contribution
to our understanding of the mechanisms by which Kidins220
regulates various aspects of synaptic plasticity. A further layer of
complexity is given by the recent identification of a number of
different Kidins220 isoforms, which show age- and tissue-specific
distribution (Schmieg et al., 2015). Such variants determine the
intracellular localization of the Kidins220 protein itself and of
its molecular partners, as shown for the TrkA receptor (Schmieg
et al., 2015). However, this field of investigation is relatively new
and many of the already identified interactions may turn out to
be isoform-specific.
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TABLE 2 | Kidins220 interacting partners, and post-translational modifications (PTMs) triggered by the interactions.
Interacting Binding site Binding site on Reciprocal Reference
partner on Kidins220 interacting PTMs
partner
AMPAR-GluA1 Transmembrane domains Not the C-terminus Kidins220 negatively
regulates GluA1
phosphorylation at
Ser831 and Ser845
Arévalo et al. (2010)
α- and β2-syntrophin PDZ-binding motif PDZ domain n.d. Luo et al. (2005)
B cell antige n receptor (BCR) n.d. n.d. n.d. Fiala et al. (2015)
B-Raf n.d. n.d. n.d. Deswal et al. (2013)
Caveolin-1 n.d. n.d. n.d. Jean-Mairet et al. (2011)
CrkL Proline-rich domain
(residues 1089–1093)
SH3 domain (constitutive
binding); SH2 domain (by
binding phospho- Tyr1096)
n.d. Arévalo et al. (2004, 2006)
EphA4 n.d. n.d. Kidins220 and
α-syntrophin induce
EphA4 Tyr
phosphorylation; EphA4
induces Kidins220 Tyr
phosphorylation
Luo et al. (2005)
ICAM-3 n.d. n.d. n.d. Jean-Mairet et al. (2011)
IKKα/β n.d. n.d. n.d. Singh et al. (2015)
Kinesin 1 KIM motif KLC residues 83–296 n.d. Bracale et al. (2007)
MAP1a, MAP1b, MAP2 Residues 760–1762 MAP1a LC2,
MAP1b LC1
Kidins220 induces
phosphorylation of
MAP1b HC, as well as
an increase in its total
levels
Higuero et al. (2010)
Na+ channels, Voltage-gated n.d. n.d. n.d. Cesca et al. (2015)
NMDA receptor subunits
NR2A, NR2B, NR1
n.d. n.d. NMDAR overactivation
reduces Kidins220
levels
López-Menéndez et al. (2009)
Olfactomedin 1 (Olfm1) n.d. n.d. n.d. Nakaya et al. (2013)
p75NTR Residues
1512–1762
Juxtamembrane region
(residues 300–315)
n.d. Kong et al. (2001) and Chang
et al. (2004)
PDZ-GEF1 Indirect binding through
S-SCAM
n.d. n.d. Hisata et al. (2007)
Pdzrn3 PDZ-binding motif First PDZ domain
(residues 249–339)
n.d. Andreazzoli et al. (2012)
Protein Kinase D (PKD) n.d. n.d. PKD phosphorylates
Kidins220 on Ser919
upon phorbol ester
treatment
Iglesias et al. (2000)
Septin 5 Residues
1603–1715
N-terminal region
(residues 125–213)
n.d. Park et al. (2010)
Sortin nexin 27 (SNX27) PDZ-binding motif PDZ domain n.d. Steinberg et al. (2013)
Statmins (SCG10, SCLIP) Ankyrin repeats n.d. Kidins220 induces Ser
phosphorylation of
statmins
Higuero et al. (2010)
S-SCAM PDZ-binding motif PDZ4 domain n.d. Hisata et al. (2007)
T-cell receptor (TCR) n.d. n.d. n.d. Deswal et al. (2013)
Trio Ankyrin repeats N-terminus
(spectrin repeats)
n.d. Neubrand et al. (2010)
TrkA, TrkB, TrkC Transmembrane domain Transmembrane domains n.d. Kong et al. (2001) and Arévalo
et al. (2004)
Tubulin-βIII, acetylated and
tyrosinated α-tubulin
n.d. n.d. n.d. Higuero et al. (2010)
VEGFR2, VEGFR3 n.d. n.d. n.d. Cesca et al. (2012)
n.d., not determined.
Some Kidins220 effects on synaptic plasticity and membrane
excitability were observed specifically in GABAergic, but not
glutamatergic neurons (Scholz-Starke et al., 2012; Cesca et al.,
2015). Since Kidins220 is expressed in both excitatory and
inhibitory neurons, this specificity may be related to the
cell-specific expression of Kidins220-interacting proteins or,
alternatively to the differential expression of KIDINS220 splice
variants (Schmieg et al., 2015). It is important to underline that
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the effects of these newly identified splice variants, as well as
of specific disease-related KIDINS220 mutations, on the cellular
localization and function of the protein are at present completely
unexplored. Finally, future studies on the role of Kidins220 in
the control of neuronal excitability will also have to consider
the complex interaction between neurons and glial cells within
the nervous system, also in view of the important role that
astrocytes (Bergami et al., 2008), oligodendrocytes (Wong et al.,
2013) and microglial cells (Parkhurst et al., 2013) play in the
modulation of numerous aspects of BDNF physiology in the CNS
and PNS.
At the level of the whole organism, it appears clear
that a dysregulation of Kidins220 physiology, may it be
caused by a variation of protein levels or by amino acid
mutations, is cytotoxic and potentially pathogenic. Interestingly,
the presynaptic roles of Kidins220 (Figure 1A) have been
identified in studies conducted on Kidins220−/− neurons, while
its function at the post-synaptic level (Figure 1B) has been
characterized mostly by acute and transient manipulation of
Kidins220 levels. Thus, although it is likely that Kidins220 exerts
all the above-described functions under physiological conditions,
it is tempting to speculate that the presynaptic effects observed
in the absence of the protein are indicative of what may happen
under pathological conditions, when Kidins220 protein levels
are drastically reduced or absent because of loss-of-function
mutations or genetic aberrations, while postsynaptic alterations
may be the consequence of physiological, activity-dependent
variations of Kidins220 levels. Although very little information
is available so far concerning the molecular pathways involved,
it is reasonable to speculate that some of the pathogenic effects
may be due to aberrant NT signaling. However, possible effects
on neuronal morphology, synaptic plasticity and membrane
excitability should not be overlooked, especially in view of the
data obtained from adult mice expressing reduced levels of
this protein (see above; Wu et al., 2009, 2010; Arévalo et al.,
2010; Duffy et al., 2011). In this respect, studies on conditional
knockout mouse lines lacking Kidins220 in a tissue-specific
fashion will be instrumental to unveil new roles of this protein
in the onset and progression of a number of pathologies,
inside and outside the nervous system. This is well exemplified
by a very recent study, in which Kidins220 was specifically
deleted in B cells (Fiala et al., 2015). Here, B cell receptor-
mediated B cell activation was reduced, thus placing Kidins220
in a central position to modulate the immune response.
Furthermore, it will be crucial to expand our knowledge of
Kidins220 mutations by performing wider screenings, including
larger populations of human patients and/or a wider range of
pathologies.
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